The PE Ratio as of November 2024 (TTM) for OKYO Pharma Limited (OKYO) is -1.84

According to OKYO Pharma Limited’s latest financial reports and current stock price. The company's current PE Ratio is -1.84. This represents a change of -95.26% compared to the average of -38.80 of the last 4 quarters.

OKYO Pharma Limited (OKYO) Historical PE Ratio (quarterly & annually)

How has OKYO PE Ratio performed in the past?

The mean historical PE Ratio of OKYO Pharma Limited over the last ten years is -1219.59. The current -1.84 PE Ratio has changed -84.91% with respect to the historical average. Over the past ten years (40 quarters), OKYO's PE Ratio was at its highest in in the December 2019 quarter at 166.94. The PE Ratio was at its lowest in in the March 2020 quarter at -1051.49.

OKYO Pharma Limited (OKYO) PE Ratio by Quarter and Year

Discovering the peaks and valleys of OKYO Pharma Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

OKYO Pharma Limited (OKYO) Average PE Ratio

How has OKYO PE Ratio performed in the past?

The current PE Ratio of OKYO Pharma Limited (OKYO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

OKYO Pharma Limited (OKYO) PE Ratio vs. Peers

How is OKYO’s PE Ratio compared to its peers?

OKYO Pharma Limited’s PE Ratio is less than Bionomics Limited (-0.22), greater than Candel Therapeutics, Inc. (-3.09), greater than Anebulo Pharmaceuticals, Inc. (-4.78), less than Cingulate Inc. (-0.00), less than Unicycive Therapeutics, Inc. (0), less than Quoin Pharmaceuticals, Ltd. (-1.63), less than Cardio Diagnostics Holdings, Inc. (-0.33), less than Virax Biolabs Group Limited (-0.79), less than PaxMedica, Inc. Common Stock (-0.67), less than Senti Biosciences, Inc. (-0.04), less than ZIVO Bioscience, Inc. (-0.14), greater than Cadrenal Therapeutics, Inc. Common Stock (-5.20), greater than Foghorn Therapeutics Inc. (-2.18), greater than Clearmind Medicine Inc. (-5.38), less than Hillstream BioPharma, Inc. (-0.65), less than Coeptis Therapeutics, Inc. (-0.99), less than Magenta Therapeutics, Inc. (-0.67), less than null (-0.15),

Build a custom stock screener for OKYO Pharma Limited (OKYO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like OKYO Pharma Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

OKYO Pharma Limited (OKYO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like OKYO Pharma Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.